An overview of prevalence, determinants and health outcomes of polypharmacy
| dc.contributor.author | Khezrian, Mina | |
| dc.contributor.author | McNeil, Christopher J. | |
| dc.contributor.author | Murray, Alison D. | |
| dc.contributor.author | Myint, Phyo K. | |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Biomedical Imaging Centre | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2020-06-16T11:10:01Z | |
| dc.date.available | 2020-06-16T11:10:01Z | |
| dc.date.issued | 2020 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 454662 | |
| dc.identifier | 163363792 | |
| dc.identifier | ad1c21df-c0a6-4ef3-8326-b873b9fad952 | |
| dc.identifier | 32587680 | |
| dc.identifier | 85086331803 | |
| dc.identifier | 000542447800001 | |
| dc.identifier.citation | Khezrian, M, McNeil, C J, Murray, A D & Myint, P K 2020, 'An overview of prevalence, determinants and health outcomes of polypharmacy', Therapeutic Advances in Drug Safety, vol. 11, pp. 1-10. https://doi.org/10.1177/2042098620933741 | en |
| dc.identifier.doi | 10.1177/2042098620933741 | |
| dc.identifier.issn | 2042-0986 | |
| dc.identifier.other | PubMedCentral: PMC7294476 | |
| dc.identifier.other | ORCID: /0000-0003-4915-4847/work/76976618 | |
| dc.identifier.other | SCOPUS: 85086331803 | |
| dc.identifier.other | ORCID: /0000-0003-3852-6158/work/163198636 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14507 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85086331803&partnerID=8YFLogxK | en |
| dc.identifier.vol | 11 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Therapeutic Advances in Drug Safety | en |
| dc.subject | health outcome | en |
| dc.subject | multimorbidity | en |
| dc.subject | older adults | en |
| dc.subject | polypharmacy | en |
| dc.subject | MORTALITY | en |
| dc.subject | DRUG-USE | en |
| dc.subject | ADULTS | en |
| dc.subject | RISK | en |
| dc.subject | DWELLING OLDER MEN | en |
| dc.subject | FRAILTY | en |
| dc.subject | CLINICAL CONSEQUENCES | en |
| dc.subject | CARE | en |
| dc.subject | ANTICHOLINERGIC BURDEN | en |
| dc.subject | EPIDEMIOLOGY | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject.lcc | R1 | en |
| dc.title | An overview of prevalence, determinants and health outcomes of polypharmacy | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Khezrian_etal_TADS_An_overview_VOR.pdf
- Size:
- 444.01 KB
- Format:
- Adobe Portable Document Format
